Symptomtext
patient was administered with an expired dose of the ActHib single-dose vial into the left deltoid , no reported adverse event; Initial information received on 30-Jun-2021 regarding an unsolicited valid non-serious case from a other health professional via Information (reference number: 00663528). This case involves an unknown age male patient who was vaccinated with an expired 0.5 ml dose of HIB (PRP/T) VACCINE [ACT-HIB] (1x single-dose vial in total, lot number UJ524AAA and expiration date 14-Jun-2021) via unknown route in the left deltoid for prophylactic vaccination on 28-Jun-2021 (expired product administered). The patient's past medical treatment(s), vaccination(s) and family history were not provided. The patient had medical history of bone marrow transplant and reported that he had 5 other vaccines along with the Act-HIB (names of the vaccine available) on 28-Jun-2021. It was a case of an actual medication error due to expired vaccine used (same day latency). At time of reporting, it was unknown whether the patient had any adverse event. It was reported that upon transfer, caller asked if there were any "cushion" after the expiration date of ActHib, where the product would still be good. Caller asked how to proceed if patient received an expired ActHib dose, and any safety concerns with having given an expired ActHib in a patient with his history. At the time of reporting, the outcome was unknown for the reported event patient. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.